New guest commentary in BioCentury by Gigi Hirsch & Jane Barlow seeds a series of discussions now underway to shape priorities for the “Next Big Thing” in the Center for Biomedical System Design and NEWDIGS.
Shifting the focus from drug cost to value must consider ‘health efficiency’—capturing the full potential value of biomedical products to society by improving appropriate, timely, and equitable access to medicines.
It’s time to help the system catch up with the science of biomedical innovation. Help us shape the “Next Big Thing” by providing your feedback below.
Read the article on
Join the conversation
What are the greatest opportunities to improve appropriate, timely, and equitable access to medicines in the US?
Share the research